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SUMMARY Excision of group II introns as 
circles has been described only for a few 
eukaryotic introns and little is known about 
the mechanisms involved, the relevance or 
consequences of the process. We report that 
splicing of the bacterial group II intron 
RmInt1 in vivo leads to the formation of 
both intron lariat and intron RNA circles. 
We determined that besides being required 
for the intron splicing reaction, the maturase 
domain of the intron-encoded protein (IEP) 
also controls the balance between lariat and 
RNA intron circle production. Furthermore, 
comparison with in vitro self-splicing 
products indicates that in vivo, the IEP 
appears to promote the use of a correct 
EBS1/IBS1 intron-exon interaction as well 
as cleavage at, or next to, the expected 
3´splice site. These findings provide new 
insights on the mechanism of excision of 
group II introns as circles. 
 
 
INTRODUCTION 
 Group II introns are large catalytic 
RNAs with a conserved secondary structure 
consisting of six domains, one of which 
(dIV) may incorporate the coding sequence 
of a reverse transcriptase (RT) (1). Although 
some group II introns self-splice in vitro, 
this reaction requires nonphysiological 
conditions, and in vivo, proteins are required 
to fold the intron RNA into a catalytically 
active structure. Group II Intron Encoded 
Proteins (IEPs) promote both splicing and 
mobility of the intron RNA through 
formation of a specific RNA-protein (RNP) 
complex (2-4). The IEPs have two 
conserved domains, an N-terminal RT 
domain and domain X, a putative RNA-
binding domain associated with maturase 
(RNA splicing) activity. In some cases the 
IEP also includes a C-terminal DNA-binding 
(D) and a DNA-endonuclease (En) domain 
(5).  
 Group II introns splice typically by 
the same two sequential transesterification 
reactions used in nuclear mRNA splicing 
(1). In a first step, the 2´-OH group of a 
branch-point nucleotide residue, usually a 
bulged adenosine in dVI, attacks the 5´ 
splice junction resulting in cleavage of the 5´ 
exon and the formation of an intron-3´exon 
branched lariat intermediate. The released 
5´exon remains associated to the intron via 
base pairing of the intron binding sites (IBS1 
and IBS2) to the exon binding sites (EBS1 
and EBS2) located in domain dI. In the 
second step, the free 3´-OH of the 5´ exon 
attacks the 3´ splice junction leading to the 
release of the intron lariat and the ligation of 
the 5´ and 3´ exons. There also exists an 
alternate pathway, in which the first splicing 
step is initiated by a nucleophilic attack of 
water or an OH- ion, resulting in the 
formation of a linear intron-3´exon 
intermediate which subsequently participates 
in a normal second step reaction. This 
hydrolytic pathway is observable in vitro 
and has been shown to be used in vivo by 
yeast mitochondrial introns carrying branch-
site mutations (6). Moreover, even though 
most of the plant chloroplast group II introns 
follow the typical lariat-generating pathway, 
hydrolytic splicing has been reported for 
intron trnV, which lacks the conserved 
bulged A in dVI, while both the hydrolytic 
and branching pathways seem to coexist in 
the case of the barley trnK intron (7). 
 Circular DNA versions of group II 
introns are known to exist in Podospora 
anserina where they are somehow 
associated with cellular senescense (8-10). 
In this particular case a model was proposed, 
by which the circular DNA molecules would 
be generated via transposition of the intron 
in front of itself, followed by excision of one 
of the tandem copies by homologous 
recombination (11-13). More recent data 
indicate that yeast intron aI5γ can be also 
excised as a true circular form in vitro (14). 
The circle seems to result from formation of 
a 2´-5´ phosphodiester bond between the last 
and first residues of the intron and it has 
been proposed that this reaction requires the 
3´exon to have been released first from 
precursor molecules (by a trans-splicing 
reaction triggered by 5´exon molecules 
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previously generated by the so-called SER -- 
spliced-exon reopening -- reaction). For the 
yeast intron aI2, both RNA and DNA circles 
have been detected in vivo and it is thought 
that circular aI2 RNAs are copied into DNA, 
presumably by reverse transcription (14). In 
addition, the presence of circular forms of 
excised intron molecules in plant 
mitochondria has been recently reported 
(15). However, circular intron molecules 
have not been described so far for bacterial 
group II introns. 
 RmInt1 is a bacterial group II 
intron identified in Sinorhizobium meliloti, 
the nitrogen-fixing symbiont of alfalfa 
(Medicago sativa). The RmInt1 IEP is 
required for intron splicing in vivo (16), but 
like those of many other bacterial group II 
introns, it lacks C-terminal DNA 
endonuclease and DNA-binding domains (5, 
17-20). RmInt1 is nevertheless an efficient 
mobile element that has two retrohoming 
pathways for mobility, with predominant use 
of the nascent lagging strand at DNA 
replication forks for priming (21). Recently, 
we reported that RmInt1 self-splices in vitro 
in the absence of the IEP, but the in vitro 
activity of the intron is atypical in that the 
second step of splicing is unusually 
inefficient and several unconventional 
products are generated alongside the 
expected excised intron and ligated exons 
(22). In this study, we have investigated the 
excision of the S. meliloti RmInt1 intron in 
vivo. Our data indicate that the RmInt1 
group II intron is excised in vivo both as 
intron lariat and intron circles and that the 
IEP seems to determine the balance between 
these two excision products. 
 
 
EXPERIMENTAL PROCEDURES 
 
 Bacterial strains, media and 
growth conditions. The strain used in this 
work was Sinorhizobium meliloti RMO17. 
This strain was cultured at 28ºC on TY 
medium for RNA extraction and RNP 
particles isolation. Escherichia coli DH5α 
was used for the cloning and maintenance of 
plasmid constructs. For plasmid 
maintenance the antibiotic kanamycin was 
added at 200 μg/ml-1 for rhizobia and 50 
μg/ml-1for E. coli. 
 
 
 RmInt1 and mutant derivatives. 
The pKG2.5, pKG2.5-YAHH, pKG2.5D5-
CGA constructs have been previously 
reported (16,17) and their main features are 
specified in the Results section. The RmInt1 
IEP maturase mutants were generated by 
site-directed mutagenesis. For the 
construction of the YY→AA mutant, two 
pairs of primers were designed in order to 
amplify the 5' and 3' sections of the IEP, 
respectively.: A 5´ end primer mut UP (5’-
GTCAGCGGTGCTGGAAGTATG-3’) and 
a 3´ end primer YY-AA/DN (5’- 
CTGTACCGTCCCGCGGCGGCAATCCA
TCCCCGAAGG-3’) were used to generate 
the upstream fragment containing 690 bp; a 
5´ end primer YY-AA/UP (5’-
GATGGATTGCCGCCGCGGGACGGTAC
AGTCGTTCGG-3’) and a 3´ end primer 
mut DN (5’-
GCGCGCGTAATACGACTCAC-3’) were 
used to generate the downstream 829 bp 
fragment. The mutagenic primers contain an 
overlapping region of 28 bp and promote the 
replacement of two conserved tyrosines 
(YY) at IEP positions 354-355 by two 
alanines (AA) through changing TAC TAT 
to GCC GCG in these positions. The final 
1492 bp amplified fragment was digested 
with EcoRI and SpeI and used to replace the 
corresponding wild-type fragment in 
pKG2.5, which generated plasmid pKG2.5-
A354A355.  
 The K381→A maturase mutant 
was constructed by site-directed mutagenesis 
using the Altered Sites II in vitro 
Mutagenesis pAlter-1 System (Promega). In 
pAL2.5-A381, which was derived from 
pAL2.5 (16), the RmInt1 nucleotides AAG 
located at positions 1687 to 1689 are 
replaced by GCG, so that the conserved IEP 
residue K381 is changed to A381. The final 
construct, pKG2.5-A381, was generated by 
cloning the RmInt1-containing fragment 
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resulting from Bam HI/ SpeI digestion of 
pAL2.5-A381 into pKG0 (17).  
 
 Primer extension assays. These 
assays were carried out on both total RNA 
and RNP particles preparations. Primer 
extension reactions were essentially as 
described previously (16). Samples were 
resolved on a denaturing 6% polyacrylamide 
gel.  
 
 
RNA isolation. RNA was extracted 
from free-living cultures of S. meliloti strain 
RMO17 containing plasmids expressing 
wild-type or mutant RmInt1 grown in 10 ml 
of TY medium supplemented with 
kanamycin until they reached an A600 of 0.6 
U. The cells were pelleted, resuspended and 
incubated for 10 min at 65°C in 300 μl of a 
lysis solution (1.4% sodium dodecyl sulfate 
(SDS), 4 mM EDTA). Proteins were 
removed by adding 150 μl of NaCl (5 M) at 
4°C for 10 min. After centrifugation, the 
nucleic acids present in the supernatant were 
precipitated by adding 1 ml of ethanol 
(100%). The pellet was resuspended in 85 μl 
of nuclease-free water and digested with 50 
U of RNase-free DNase I (Roche). The RNA 
was extracted with 1 volume of a 25:24:1 
mix of phenol 
(pH4.5)/chloroform/isoamylalcohol and then 
extracted with 1 volume of a 24:1 mix of 
chloroform/isoamylalcohol. Finally the RNA 
was precipitated with 3 volumes of ethanol 
(100%) and 75mM NaOAc pH5.2. The RNA 
pellet was washed with 70% ethanol, dried 
and resuspended in 20μl nuclease-free water. 
For the RT-PCR assays shown in Figure 5B, 
RNA preparations were set up with a few 
modifications. Proteinase K (25 µl of a 
solution of 5mg/ml) was added to the lysis 
solution followed by the procedure 
described above or after DNase I digestion 
the sample was treated with 25 μl guanidine 
thiocyanate 5M, 2.5 μl NaOAc 3M pH4.8, 
93 μl phenol pH4.5 and 30 μl 
chloroform/isoamyl alcohol (49:1) for 15 
min on ice and then extracted with 
chloroform/isoamyl alcohol (24:1).  
Preparation of RNP particles. 
RNPs isolation was carried out essentially as 
described previously (16). The clarified 
lysate (5 ml) was layered on a 5 ml 1.85M 
sucrose cushion and centrifuged for 20 h in a 
Beckman Ti50 rotor at 50,000 rpm. A 
supernatant with two different fractions 
according to its density (S1, light and S2, 
dense) and a pellet (P) containing the RNPs 
was obtained. For the RT-PCR assays shown 
in Figure 5A, the two fractions of the 
supernatant (~5 ml each) were collected and 
precipitated. The S2 fraction was 
precipitated with three volumes of ethanol 
(100%) and 0.8M LiCl. The resulting pellet 
was resuspended in water and precipitated 
again with three volumes of ethanol and 
0.25M NaOAc pH5.2. The S1 fraction was 
mixed with 1.5 volumes of a solution 
containing 0.8M guanidine thiocyanate, 
50mM NaOAc pH4.8 and phenol 
pH4.5/chloroform/isoamyl alcohol 
(150:49:1). The mixture was kept on ice for 
15 min and centrifuged at 13,000 rpm for 15 
min. The supernatant was extracted with 
chloroform/isoamyl alcohol (24:1) followed 
by precipitation with one volume of 
isopropanol. The resulting pellet was 
resuspended in water and digested with 100 
U RNase-free DNase I (Roche) followed by 
phenol (pH4.5)/chloroform/isoamylalcohol 
(25:24:1) extraction and isopropanol 
precipitation. 
 
 
 RT-PCR and cRT-PCR assays. 
First strand cDNA synthesis was started by 
annealing 6.5 μg of total cellular RNA or an 
equivalent quantity of RNPs (0.1625 A260 
units) and 25 pmol of Ect1 primer 
complementary to a sequence 188 nt from 
the 5’ end of RmInt1 in presence of 12.5 nM 
dNTPs equimolar mix. The mixture was first 
heated at 90ºC for 2 min, then was slowly 
cooled for 15 min prior to being put on ice 
for 15 min. cDNA synthesis was triggered 
by addition of first strand reverse 
transcriptase buffer 5x (Invitrogen), 0.2 mol 
DTT, 30 units RNAguard™ RNase inhibitor 
(Amersham Biosciences) and 400 units 
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SuperScript II RNase H- reverse 
transcriptase (Invitrogen) for 120 min. After 
heat inactivation of the enzyme (at 70ºC for 
15 min), RNase H digestion was carried out 
for 20 min at 37ºC. One fifteenth of that 
reaction was used as a template in the PCR 
with 30 pmol of LL primer (5’-GAG GTT 
CAC GCA CCG TTC TG; designed 
complementary to a sequence 59-40 nt from 
3’ end of RmInt1), 30 pmol of 5’-
radiolabelled P primer (around 200,000 
CPM), 12.5 mmol dNTPs mix, 50mM 
HEPES (pH 7.9), 1.5mM MgCl2, 50 mM 
KCl and 2 U Taq polymerase in 50 μl as 
final volume. After the preincubation step at 
94ºC for 3 min, 35 cycles was performed: 45 
sec at 94ºC, 30 sec at 63ºC, 30 sec at 72ºC 
and a final extension at 72ºC for 10 min. 
One μl of RT-PCR product was separated on 
a denaturing 6% polyacrylamide gel. 
Subsequent cloning in pGEM-T easy vector 
(Promega) and sequence analysis of the RT-
PCR products was carried out by isolation of 
the corresponding bands from agarose gels.  
The cRT-PCR experiments were carried out 
as the RT-PCR assays, but using previously 
ligated RNA samples to circularize any 
linear intron molecules which contain a 
5´monophosphate. Twenty-five micrograms 
of total RNA or 0.625 A260 units of RNP 
particles preparation from wild-type intron 
pKG2.5 cells were added to a solution 
containing 50 mM Tris-HCl (pH 7.8), 10mM 
MgCl2, 10mM DTT, 1mM ATP and 50 units 
of T4 RNA ligase (New England Biolabs) in 
a final volume of 20 μl and the mixture was 
incubated at 37ºC for 2hr. Subsequently, T4 
RNA ligase was inactivated by boiling for 2 
min and the reaction underwent phenol and 
chloroform extractions followed by ethanol 
precipitation for 1 hr at -80ºC. Finally, 
samples were resuspended in 5 μl of DEPC-
water and 2.5 μl were used for reverse 
transcription.  
 
 RT assays. Exogenous RT activity 
in RNP particles was measured as previously 
described (16).  
 
RESULTS 
 
RmInt1 excised products in vivo as 
determined by primer extension. 
 Since the RmInt1 ribozyme has a 
bulged A located seven nucleotides 
upstream of the 3´ splice site, we expected 
the intron to splice primarily as a lariat in 
vivo. Initially, we characterized the RmInt1 
splicing reaction by primer extension using a 
primer P (Figure 1) complementary to a 
sequence located 80-97 nt from the 5´end of 
the intron (16). Interestingly, primer 
extension assays using RNA and RNP 
particles from S. meliloti cells expressing 
wild-type intron pKG2.5 revealed two 
extension products (along with larger bands) 
that differ by one nucleotide (97-98 nt; 
Figure 1) relative to the position expected 
for the 5´end of the intron. Note that the 
shorter 97 nt extension product is clearly a 
major product in both RNA and RNP 
particles preparations. None of these two 
extension products were detected with RNA 
or RNPs isolated from cells harboring the 
splicing-defective intron pKG2.5D5-CGA, 
which has a mutation (GUU→GCA) in the 
AGC-GUU critical conserved pairing of 
ribozyme domain dV (Figure 1, lanes 2 and 
4). Therefore, we conclude that the 97 and 
98 nt extension products were derived from 
excised intron RNA molecules.  
 While primer extension data do not 
by themselves make it possible to clarify the 
nature of the excised intron RNA, it is 
interesting to note that primer extension 
performed on a circular intron has been 
reported to result in two extension products 
that differ by one nucleotide, the longer 
product being the major one (14). Reverse 
transcriptase is known to pause after reading 
through the 2´-5´ linkage in a non lariat 
RNA (23), whereas with lariat RNA, the 
pause occurs before reading through the 2´-
5´linkage (14). Thus, one possible 
interpretation of our data was that in 
addition to intron lariat, RmInt1 might be 
excised in vivo as intron circles. 
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Detection of two different RmInt1 
excision products in vivo by reverse 
transcription and PCR 
 To further investigate the nature of 
RmInt1 excision products, RNA and RNP 
particles preparations were analyzed by 
reverse transcription with primer Ect1 
(Figure 2A), located downstream of the 
5´splice site, followed by PCR with primers 
P and LL, the latter located 5´ of the branch 
site (Figure 2A). The PCR products were 
radiolabeled using a 5´-end-labeled P primer 
and the products were separated on a 
denaturing, 6% (w/v) polyacrylamide gel 
(Figure 2B). When RNA samples were used 
(Figure 2B), two major products of 265 nt 
and 156 nt were observed in cells expressing 
the wild-type intron pKG2.5 (lanes 2) or the 
defective homing mutant pKG2.5-YAHH 
(lane 4), which has a YADD to YAHH 
mutation in the RT domain and therefore 
cannot generate duplicated linear introns 
joined head-to-tail. The 265 nt product was 
also present in the splicing-defective mutant 
pKG2.5D5-CGA (lane 6), indicating that it 
was not derived from spliced intron; as 
shown later, this product derives from the 
RNA precursor. Strikingly, the 156 nt 
product, whose size is that expected from a 
circular RNA substrate in which the first G 
residue of the intron is linked to the last C 
residue, was absent when RNA from the 
splicing-defective mutant pKG2.5-D5-CGA 
was used (lanes 6) or when reverse 
transcription was omitted (lanes 1, 3 and 5). 
These results indicate that the RT-PCR 
product of 156 nt obtained using RNA 
samples is primarily derived from an excised 
intron RNA product.  
 The 156 nt RT-PCR products were 
also detected when preparations of RNP 
particles from cells expressing the wild-type 
intron pKG2.5 were used (Figure 2B, lane 
8). Consistent with the data reported above, 
the 156 nt product was not seen when 
mutant pKG2.5-D5-CGA RNP particles 
were used (lane 12). This product was 
clearly reduced in RNP particles from the 
RT mutant pKG2.5-YAHH (lane 10) that 
has ∼60% of the wild-type splicing activity 
(not shown). Interestingly, in the absence of 
reverse transcription and the primer Ect1, a 
PCR product of 156 nt was still clearly 
detected in wild-type intron pKG2.5 RNP 
particles (lane 7), but was not observed in 
the splicing defective mutant pKG2.5-D5-
CGA (lane 11). These results appear to 
indicate the existence of DNA molecules 
generated from spliced intron circles. 
 In addition to the aforementioned 
products, in the RNP particles, but not in the 
RNA samples (Figure 2B), we detected 
another major RT-PCR product of 150 nt, 
whose size is that expected from a substrate 
consisting of an intron lariat in which the 
branching point is the bulged A in dVI. This 
product was observed in both wild-type 
intron pKG2.5 (lane 8) and the RT mutant 
pKG2.5-YAHH (lane 10), but was absent in 
the splicing-defective mutant pKG2.5D5-
CGA (lane 12) or when reverse transcription 
was omitted (lanes 7, 9 and 11). These 
results imply that the RT-PCR product of 
150 nt is generated from the amplification of 
a second intron RNA excision product.  
 
 
RmInt1 excision in vivo produces both 
lariat and intron circles  
 The amplified RT-PCR products 
from both RNA and RNP particles 
preparations were gel-extracted, cloned and 
sequenced. All nineteen clones generated by 
the 265 nt RT-PCR product from wild-type 
intron pKG2.5 and RT mutant pKG2.5-
YAHH, and either RNA or RNP particles, 
showed 168 nucleotides of the 5´exon joined 
to 97 nucleotides of the 5´-end of the intron. 
A similar result was obtained by sequencing 
nine clones from a 265 nt PCR product 
obtained in the absence of reverse 
transcription using RNP particles 
preparations from RT mutant pKG2.5-
YAHH. Therefore, we conclude that as 
stated above, this amplification product is 
generated from intron RNA precursor and/or 
contaminant DNA.  
 The RT-PCR products of 156 nt 
generated from RmInt1 excised intron using 
RNA samples (Figure 2B) were also cloned 
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and sequenced. Ten of eleven clones from 
the RT mutant pKG2.5-YAHH were derived 
indeed from intron RNA circles and 
displayed the expected point of circular 
ligation between the first and last residues of 
the intron (Figure 2C), while the remaining 
one (157 nt) corresponded to a molecule 
with an extra cytosine at the site of 
circularization. Similar results were obtained 
when the same RT-PCR product was 
sequenced from wild-type intron pKG2.5. 
Five of nine clones corresponded to the 156 
nt intron circle product, while the remaining 
four displayed an additional cytosine (157 
nt). Together, these findings are consistent 
with the production of intron RNA circles in 
vivo. The PCR product of 156 nt obtained in 
the absence of reverse transcription and 
primer Ect1 when wild-type intron pKG2.5 
RNP particles were used (Figure 2B, lane 7) 
was also cloned and sequenced. All six 
clones analyzed had the same sequence as 
the RT-PCR product of 156 nt generated 
from the RNA samples. We interpret the 
latter molecules as evidence that in addition 
to RmInt1 intronic circular RNA, there exist 
intronic DNA circles.  
 In agarose gels, the coexisting RT-
PCR products of 150 nt and 156 nt (Figure 
2B, lanes 8 and 10) generated by 
amplification of RNP particles samples from 
either wild-type intron pKG2.5 or RT 
mutant pKG2.5-YAHH can not be resolved 
(data not shown). Therefore, the amplified 
products were isolated together, cloned and 
sequenced. Eleven of thirteen clones from 
wild-type intron pKG2.5 showed the 
expected linkage between the bulged A of 
dVI and the first residue of the intron 
(Figure 2C), indicating that they arose from 
a lariat intron, while the remaining two 
correspond to intron circles. Note that in the 
products amplified from lariat intron (Figure 
2C), there was misincorporation of 
adenosine instead of thymidine as reverse 
transcriptase encountered the branched 
nucleotide (7,24). Consistent with the higher 
proportion of the 150 nt RT-PCR product in 
the RT mutant pKG2.5-YAHH (Figure 2B, 
lane 10), all ten derivative clones had the 
sequence expected from a lariat intron. 
Together, these findings imply that excision 
of RmInt1 in vivo produces intron lariat as 
well as intronic RNA and DNA circles. 
 
 
RmInt1 RNA molecules detected by cRT-
PCR. 
 It has been suggested that intron 
circle formation by intron aI5γ could result 
from the previous release of the 3´ exon by 
free 5´ exon molecules arising from the exon 
reopening reaction (SER) (14). RmInt1 
circles might also be originated by ligation 
of the ends of a previously linear intron 
molecule produced by the hydrolytic 
pathway in which the first splicing step 
results in the formation of a linear intron-
3´exon intermediate. To test for the possible 
presence of such intermediates in the RNA 
population, the RNA was circularized using 
T4 RNA ligase prior to reverse transcription 
with primer Ect1 and PCR with primers P 
and LL (cRT-PCR) (7). Since the resulting 
products from both total RNA and RNP 
particles form a smear in polyacrylamide 
gels (not shown), they were cloned directly 
from the PCR reaction. As shown in Figure 
3, sequence analysis of pKG2.5 samples (8 
clones from total RNA and 8 clones from 
RNP particles) revealed a predominance of 
molecules in which the 5´ exon was ligated 
either to the exact 3´ end of the intron (C-
1884) or to one of the nucleotides 
neighboring the 3´ splice site (9 out of 16 
clones). Moreover, the 5´ end of the RNA 
precursor seems to be primarily processed 
around nucleotide -30. Five other clones 
contained the intron flanked by 5´ and 3´ 
exon sequences, presumably representing 
intron RNA precursor molecules, while the 
remaining two clones likely corresponded to 
molecules degraded either at the 5´ or 3´ 
end. These results are consistent with the 
suggestion that the release of the 3´exon 
might be the first step for RmInt1 circle 
formation.  
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The maturase domain is required for 
RmInt1 splicing and intron circle 
formation. 
 In group II intron-encoded proteins 
(IEPs), the RT domain is followed by a 
region denoted domain X, affecting the 
maturase (RNA splicing) activity. To assess 
the involvement of the maturase domain of 
RmInt1 in the splicing reaction in vivo and 
intron circle formation, we created the 
mutant YY→AA, which has two alanine 
residues instead of the conserved Y354 and 
Y355 residues, and the mutant K381→A, in 
which the conserved K381 residue is 
replaced by an alanine residue (Figure 4A). 
Primer extension analysis and RT-PCR 
assays using both RNA and RNP particles 
preparations indicate that the YY→AA 
mutant shows no detectable splicing 
(Figures 4B and 4D). Moreover, the RNP 
particles from cells expressing pKG2.5-
A354A355 had strongly decreased RT 
activity similar to that of the RT YAHH 
mutant (Figure 4C), consistent with the 
inability of these mutants to form active 
RNP particles. As expected from these data, 
mobility is abolished in the YY→AA mutant 
(data not shown). These findings indicate 
that as expected the RmInt1 maturase X 
domain is required for the splicing reaction 
in vivo, and also for RNA intron circle 
formation.  
 As shown in Figure 4B, the single point 
mutation K381→A inhibits, but does not 
abolish splicing (∼30% wild-type). Also, the 
RNP particles of cells expressing pKG2.5-
A381 have strongly decreased RT activity 
(Figure 4C) and the K381→A mutant has no 
detectable mobility (data not shown). 
Interestingly, RT-PCR assays using RNP 
particles preparations from this mutant 
(Figure 4D) showed an apparent bias to 
intron circles formation (compare the levels 
of products derived from the lariat and 
intron circles between the mutant, lane 10, 
and the wild type, lane 12). Moreover, the 
RT-PCR product of the K381→A mutant 
corresponding to intron circles appears to be 
primarily one nucleotide longer than that 
obtained from the wild-type intron. This was 
confirmed by sequencing the cloned RT-
PCR product, which showed an extra C 
residue at the circle ligation point. The 
apparent shift from lariat to intron circles 
might only reflect a decrease affinity of the 
mutant RT-maturase for the lariat product 
leading to a reduction of lariat intron in the 
RNP particles. To assess this possibility the 
RNA from the supernatant fractions S1 and 
S2 after the RNPs (P) pelleting step were 
also analyzed by RT-PCR (Figure 5A). In 
the case of the wild-type intron (pKG2.5), 
the RT-PCR product derived from the lariat 
was the prominent product in both the RNPs 
(P) and the dense fraction of the supernatant 
(S2), whereas in the light fraction of the 
supernatant (S1) similar levels of RT-PCR 
products derived from lariat and intron 
circles was observed. Interestingly, in the 
last fraction (S1) intronic DNA circles were 
detected (reverse transcription and primer 
Ect1 omitted, lane1). On the contrary, in the 
K381→A mutant the major RT-PCR 
product in the RNPs (P) and in both 
supernatant fractions (S1 and S2) was 
derived from intron circles. These findings 
are consistent with a genuine shift from 
lariat to intron circles production in the 
K381→A mutant. Nevertheless, this 
conclusion was still hampered by the fact 
that in the total RNA preparations we had 
only detected intron circles by RT-PCR, 
hence we could not differentiate the mutant 
from the wild-type intron. A possible 
explanation is that the lariat RNA could be 
degraded or the RNP particles eliminated in 
some way during the RNA isolation. To 
asses this possibility we also obtained total 
RNA using methods that included specific 
steps of denaturation or removal of proteins. 
As shown in Figure 5B either the use or 
guanidine thiocyanate or proteinase K in the 
RNA isolation procedure allowed us to 
detect both lariat and intronic circles in the 
RNA samples. As expected the RT-PCR 
product derived from lariat molecules is the 
predominant product in the wild type intron 
pKG2.5, but again the RT-PCR product 
derived from intron circles was the major 
product in the K381→A mutant. Thus, taken 
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together these findings indicate that the 
maturase domain X of the IEP controls the 
balance between lariat and RNA intron 
circle production. 
 
 
DISCUSSION 
 
 We show here that the S. meliloti 
group II intron RmInt1 is excised in vivo 
both as intron lariat and intron circles and 
that the maturase domain of the IEP is not 
only required for intron RNA splicing, but 
plays a role in the mechanism chosen for 
intron excision.  
 
 
RmInt1 is excised as a lariat but also as 
intron circles in vivo. 
 By RT-PCR and sequencing, we 
found that excision of the RmInt1 wild-type 
intron from its RNA precursor produces both 
lariat and RNA circular molecules. RNA 
intron circles are also produced by a mutant 
in the RT active site (YAHH) and by the 
maturase mutant K381→A. Since these 
mutant introns are not mobile and therefore, 
can not generate intron dimers arranged 
head-to-tail, we believe that PCR products in 
which the intron 5' and 3' ends are joined 
together were not generated by transcription 
of intron duplications, but rather reflect the 
presence of genuine RNA circles resulting 
from intron excision. It should be added that 
RmInt1 also generates RNA circles in a 
RecA- background (data not shown), which 
adds further support to the above conclusion. 
Our data also suggest that not only RNA 
circles, but DNA circular molecules are 
produced as well by the wild-type RmInt1 
intron; whether the latter molecules are 
generated through reverse transcription of 
the RNA circles by the IEP remains to be 
determined.  
 The circle produced in vitro by the 
yeast intron a5γ seems to result from 
formation a 2´-5´ bond and this may also be 
the case for RmInt1 RNA circles. Although 
the absolute ratio of intron circle over lariat 
cannot be estimated from these assays since 
RT-PCR is bound to be influenced by the 
differing ability of reverse transcriptase to 
read through 2´-5´linkages depending on 
whether these are part of branched (lariat) or 
unbranched (intron circle) structures (14,23), 
the RT-PCR assays suggest that the lariat is 
the predominant excision product of wild-
type intron RmInt1. The detection of lariat 
intron molecules in the RNA preparations, 
but not the circular forms depends on the use 
of specific steps of denaturation or removal 
of proteins during the RNA isolation. In 
addition, the RT-PCR analysis of the 
supernatant fractions and the pellet after the 
RNPs pelleting step suggests that the lariat 
associated with the IEP (RNPs) and the 
intronic circles have different hydrodynamic 
properties. These properties may be 
influenced by both the type of folding of the 
different excised intron molecules and a 
distinctive interaction of these forms with 
the IEP.  
 
 
The role of the RmInt1 IEP in splicing 
and intron excision as circles in vivo. 
 A mutation in which the conserved 
Y354-Y355 residues of the RmInt1 IEP 
maturase domain were replaced by two 
alanine residues abolished formation of both 
RNA circles and intron lariat, thus implying 
that the maturase domain X is required for 
the two excision mechanisms in vivo. The 
mutation Y354-Y355→AA may inhibit 
RNA splicing directly by altering some of 
the contacts of the IEP with the intron RNA 
or by decreasing the stability of the IEP. In 
the maturase mutant K381→A splicing was 
reduced to 30% of the wild-type and there 
was a marked decrease of intron lariat 
molecules. This mutation may also alter the 
IEP interaction with the intron RNA, which 
in turn may affect the intron excision 
mechanism. Our results suggest that the 
maturase domain X controls in some way 
the balance of intron excision as lariat or 
intron circles. Moreover, we found that some 
of the amplified products presumably 
derived from RmInt1 RNA circles contain 
an extra cytosine at the circle ligation point. 
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Noticeably, those products predominate 
among molecules amplified from the 
maturase mutant K381→A. The addition of 
non-encoded nucleotides at the circle 
ligation point was observed for in vitro-
generated circular aI5γ RNA (14) and the 
inserted residues were hypothesized to 
having been incorporated by the reverse 
transcriptase used in the assays when it 
encounters the putative 2´-5´phosphodiester 
bond. However, a cytosine residue (IBS3) is 
also present at position +1 of the RmInt1 3´ 
exon. Thus, the extra C residue in the 
RmInt1 RNA circular molecules might arise 
from cleavage at position +1 (IBS3) in the 
3´exon, rather than being an artifact of the 
reverse transcription reaction. This plausible 
interpretation of our results implies that the 
maturase would help to determine the 
precise site of excision at the 3´ splice 
junction during intron circle formation.  
 
 
The mechanism of RmInt1 excision as 
circles in vivo. 
 While RmInt1 is also able to form 
RNA intron circles in the absence of protein 
by using a pseudo-IBS1 (IBS1*) sequence 
located close to the correct 3' splice site in 
the 3´exon (22), the IEP seems to promote 
the correct EBS1-IBS1 interaction in vivo. 
Analysis of intron-containing RNA using T4 
RNA ligase assays revealed a predominance 
of intermediates with a site of 3' exon 
cleavage located at or next to the 3´splice 
site. Thus, in vivo the presence of the IEP 
seems to ensure that cleavage occurs either 
at the correct 3´ splice site or at position +1 
of the 3´exon before intron RNA circle 
formation, rather than at position +10 or +11 
as occurs in vitro (22). After the release of 
the 3´ exon, which may result from a trans-
splicing reaction as suggested for intron aI5γ 
(14), the 2'OH of the terminal cytosine will 
attack the 5´splice site, releasing the 5´exon 
and an intron circle.  
 Excision of group II introns as 
circles had been shown to occur in vivo for 
yeast introns like aI2 (14) and for some plant 
mitochondria introns (15), but is reported for 
the first time in this work for a mobile 
bacterial group II intron. It is now apparent 
that this peculiar mode of excision is more 
widespread in nature than it seemed and we 
regard it as likely that it will be found to 
have a biological role, perhaps with respect 
to intron spread and dissemination. 
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FIGURE LEGENDS 
 
Figure 1. Primer extension analysis of RmInt1 splicing in vivo. A. Total RNA and RNP 
particles were isolated from S. meliloti RMO17 strain harboring the wild-type intron pKG2.5 
and the splicing-defective mutant pKG2.5D5-CGA. The RNA and RNP particles preparations 
were reverse transcribed with an intron-specific primer (P). The cDNA products of 97 and 98 
nt derived from excised intron RNA are indicated. B. Schematic illustration of primer 
extension on linear, lariat and intron circle showing the expected extension products. The 
bulged A in dVI is also indicated. 
 
Figure 2. Characterization of RmInt1 excision as lariat and intron circles in vivo. A.  
Schematic representation of group II intron RmInt1 and the intron-encoded protein (IEP) 
coding sequence in dIV. The primer used for cDNA synthesis, Ect1, and the primers used for 
PCR amplification (P and LL) are indicated with arrows together with their respective 5´ end 
nucleotide position along the intron DNA sequence. The nucleotide positions of the splice 
junctions are indicated below the schematic representation of the precursor RNA. B. RT-PCR 
and PCR analysis of RNAs and RNP particles from RmInt1 and mutant derivatives. 
Reactions were carried out with RNA from S. meliloti RMO17 harboring pKG2.5, pKG2.5-
YAHH and pKG2.5D5-CGA, with (+) and without (-) previous reverse transcription (RT). 
The identified products and their sizes are indicated as well as a representation of the PCR 
products for the intron lariat, intron circle and RNA precursor/contaminant DNA. Analysis of 
the DNA sequence of the 5' exon indicates a possible mispriming of primer LL (showed as 
dot in Figure 2A) that will account for the amplification of a 265 nt product. C. The intron 
lariat and the intron RNA circle are also represented, showing the cDNA extension and PCR 
reactions. The circled A corresponds to the bulged adenosine in dVI. In the RNA circle the 
first residue of the intron (G) is ligated to its last residue (C) or to the first residue of the 
3´exon (+1C). The expected RT-PCR products derived from intron lariat and intron circle are 
shown and their size in bp indicated. Finally, the nucleotides around the 2´-5´ linkage for the 
intron lariat, or surrounding the point of ligation for the intron circle, are shown as they 
appear in RT-PCR products. 
 
Figure 3. cRT-PCR detection of RmInt1 RNA molecules. A. Sequence analysis of clones 
obtained by cRT-PCR from RNA and RNP particles preparations of wild-type intron 
pKG2.5. Terminal nucleotide positions of the intron-containing RNA intermediates in the 5´ 
and 3´ exons or within the intron are shown. C-1884 is the last residue of the intron. B. 
Schematic illustration of RmInt1 flanked by the 5´and 3´exons. Nucleotide positions relative 
to the RmInt1 insertion site are indicated. The main intron containing RNA intermediates 
(RNA precursors and 5´exon-intron products) deduced from the T4 RNA ligase assays are 
indicated below.  
 
Figure 4. The RmInt1 IEP maturase domain X is required for splicing and contributes 
to the formation of both lariat and intron circles. A. Diagram of the constructed maturase 
domain mutants pKG2.5-A354A355 and pKG2.5-A381. B. Primer extension analysis of 
maturase mutant splicing in vivo. The cDNA products of 97nt and 98 nt derived from excised 
intron RNA are indicated. Splicing efficiencies in RNA samples were also plotted as 
percentage of wild-type values determined in pKG2.5. C. RT assays with exogenous 
templates. The RT assays were carried out by incubating RNP particles with the exogenous 
substrate poly(rA)/oligo(dT)18. The c.p.m. values (means ± S.D.s for three determinations) 
were plotted as percentage of the wild-type value determined in pKG2.5. D. RT-PCR assays 
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with RNAs and RNP particles from RmInt1 and maturase mutant derivatives. The products 
derived from intron lariat (150 nt) and intron circle (156 nt) are represented at the right side 
of the panel. 
 
Figure 5. The maturase domain of the IEP controls the balance between lariat and 
intron RNA circles. A. RT-PCR detection of circular and lariat excised forms in the 
supernatant fractions and pellet after the RNPs pelleting step in RNP preparations. The two 
fractions of the supernatant, light (S1), dense (S2), and the RNPs (P) pellet were assayed. The 
RT-PCR products obtained from the wild-type intron pKG2.5 and the maturase mutant 
pKG2.5-A381 are shown. The splicing defective mutant in the catalytic domain dV 
pKG2.5D5-CGA was used as a control. Reactions were carried out with (+) and without (-) 
previous reverse transcription (RT). The molecular sizes of the products are indicated. 
Circular (C) and lariat (L) derived RT-PCR products are indicated. B. Determination of the 
shift of lariat to circles production in the maturase mutant K381→A in total RNA. RNA 
isolation was carried out by using modification to the basic (Φ) protocol, a treatment with 
proteinase K (K) or a treatment with guanidine thiocyanate (G) were included.  
 





